Juan He
State Key Laboratory Of Systems Medicine For Cancer
Shanghai, 200025, China
Shanghai, 200025, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 35 publications
Ecosystem functions and network complexity do not increase linearly with restoration levels on China's loess plateau.
Journal: Journal of environmental management
Published: April 20, 2026
Corrigendum to "The vulnerabilities of chemotherapy resistant pancreatic cancer revealed by organoids of pre- and post- neoadjuvant therapy" [Cancer Lett. (2026), Online ahead of print].
Journal: Cancer letters
Published: February 06, 2026
Eculizumab-Induced Acute Heart Failure Decompensation in a Patient with Clinically Suspected Complement-Mediated Thrombotic Microangiopathy: A Case Report.
Journal: Infection and drug resistance
Published: January 28, 2026
Polymyxin-Associated Neurotoxicity: A Case of Guillain-Barré Syndrome Temporally Linked to Colistin Methanesulfonate and Respiratory Paralysis with Polymyxin B.
Journal: Infection and drug resistance
Published: November 08, 2025
Theoretical differentiation between Miu Ci and Ju Ci in Huangdi Neijing
Journal: Zhongguo zhen jiu = Chinese acupuncture & moxibustion
Published: April 22, 2025
A pancreatic cancer organoid biobank links multi-omics signatures to therapeutic response and clinical evaluation of statin combination therapy.
Journal: Cell stem cell
Published: June 12, 2024
Integrated characterization of hepatobiliary tumor organoids provides a potential landscape of pharmacogenomic interactions.
Journal: Cell reports. Medicine
Published: February 23, 2023
Metabolic classification suggests the GLUT1/ALDOB/G6PD axis as a therapeutic target in chemotherapy-resistant pancreatic cancer.
Journal: Cell reports. Medicine
Published: January 03, 2023
Functional hepatobiliary organoids recapitulate liver development and reveal essential drivers of hepatobiliary cell fate determination.
Journal: Life medicine
Published: September 07, 2022
FOXA2 drives lineage plasticity and KIT pathway activation in neuroendocrine prostate cancer.
Journal: Cancer cell
Published: February 08, 2022
Last Updated: 09/26/2026